Crinetics Pharmaceuticals (CRNX) Times Interest Earned (2017 - 2026)
Crinetics Pharmaceuticals' (CRNX) quarterly Times Interest Earned came in at -$1.15 in Q1 2026, up 97.93% year-on-year from -$0.58 in Q1 2025, and down 102.86% quarter-over-quarter from $40.43 in Q4 2025.
Crinetics Pharmaceuticals (CRNX) Times Interest Earned (2017 - 2026) Analysis & Trends
Crinetics Pharmaceuticals' Times Interest Earned history runs 10 years deep, the most recent figure standing at -$1.15 for Q1 2026.
- On a quarterly basis, Times Interest Earned rose 97.93% year-over-year to -$1.15 in Q1 2026; TTM through Mar 2026 was -$4.49, a 99.35% increase from a year earlier, with the FY2025 full-year figure at -$1.32, down 31.35% from the prior year.
- Times Interest Earned slipped to -$1.15 in Q1 2026 per CRNX's latest filing, from $40.43 in the prior quarter.
- Across five years, Times Interest Earned topped out at $313.29 in Q4 2023 and bottomed at -$158.52 in Q4 2022.
- The 5-year median for Times Interest Earned is -$0.78 (2022), against an average of $10.95.
- Across the five-year window, Times Interest Earned jumped 297.63% in 2023 and slumped 25788.49% in 2025, its largest moves.
- Year by year, Times Interest Earned stood at -$158.52 in 2022, then soared by 297.63% to $313.29 in 2023, then sank by 80.5% to $61.09 in 2024, then sank by 33.81% to $40.43 in 2025, then slumped by 102.86% to -$1.15 in 2026.
- Per Business Quant, the three latest CRNX Times Interest Earned figures stand at -$1.15 (Q1 2026), $40.43 (Q4 2025), and -$0.71 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 7.60 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -0.22 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -0.38 |
| 10 | Crinetics Pharmaceuticals | 8.71 Bn | 8.71 Bn | 10.53 Mn | -1.15 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.15 |
| Dec 31, 2025 | 40.43 |
| Sep 30, 2025 | -0.71 |
| Jun 30, 2025 | -1.59 |
| Mar 31, 2025 | -55.70 |
| Dec 31, 2024 | 61.09 |
| Sep 30, 2024 | -0.25 |
| Jun 30, 2024 | -0.29 |
| Mar 31, 2024 | -0.22 |
| Dec 31, 2023 | 313.29 |
| Sep 30, 2023 | -0.41 |
| Jun 30, 2023 | -2.38 |
| Mar 31, 2023 | -3.36 |
| Dec 31, 2022 | -158.52 |
| Sep 30, 2022 | -1.57 |
| Jun 30, 2022 | -1.79 |
| Mar 31, 2022 | -0.78 |
| Dec 31, 2021 | -102.96 |
| Sep 30, 2021 | -0.66 |
| Jun 30, 2021 | -0.78 |